Clinical Trial Results

Showing: All studies [change]
Condition: Multiple Sclerosis Location: Oklahoma 6 trials found
New Search
Filter
Trial Phase
What's the difference?
Study Type
What's the difference?
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
PHASE4INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
PHASE2INTERVENTIONAL Boston, Massachusetts +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Skeletal Muscle Aging and Responsiveness in Aged People With MS
NAINTERVENTIONAL Oklahoma City, Oklahoma
RECRUITING
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type